Flickr/NIAIDColorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification). Shares of Tekmira Pharmaceuticals, which is working on a treatment for Ebola, are surging in after hours trade after the Centers for Disease Control confirmed the first case of Ebola in the US. Shares of Tekmira were up as much 11% on Tuesday evening. Shares of BioCryst Pharmaceuticals, which is also working to develop an Ebola treatment, were also up more than 14% in after hours trade on Tuesday. Other pharmaceutical companies, including Sarepta Therapeutics, up 7%, and NewLink Genetics, up 14.5% were also higher following the news. All of these companies, in some form or fashion, have been working on treatments for Ebola.  FREE AppDownload
